With 30 years global experience in life science and convergent technology innovation, we are experienced veterans in the sector, with substantial knowledge in fundraising, project management and health technology development.

With career long experiences in gene therapy, cell therapy and regenerative medicine, both in research and development and project management, we also have significant expertise in fund raising (over €150 Mn raised), international project management (over 20 large scale international programmes and projects), and 5 years experience in diagnostics, patient care and management solutions, that can be applied to academic and industrial projects or projects that integrate the two.


Leveraging collaborative expertise in health technology development including health technology assessments (HTA s)  on a Global, Regional and country level we have also developed a novel valuation model that integrates pre-clinical, clinical, HTA and commercial potential allowing for optimised value making decisions throughout the whole life cycle of intervention development.

Innovator focused multi-stakeholder briefings by indication and continental marketplace can be found on out 'Innovator briefings' page.


Rare neuromuscular diseases and PROMs: The impact of payer and reimbursement authorities evidence requirements on healthcare solution design: link

A novel valuation model for medical intervention development: link

Patient power – the importance of patients and patient associations in Rare Disease intervention design and validation: link


A common apothecary cabinet – redesigning personalised medicines for Rare and age related diseases: link

A Cloud or a Perfect Storm? Assessing current status and future needs in Digital Health: link


Maximising outputs from early stage collaborations: how to make an optimal international R&D ecosystem organisation: link


2090..or 2020 – the future of regenerative medicine: link

The relevance of reimbursement rates and approved solution applicability on ROI: reassess your risk: link

Addiction to legal products - Tobacco and Alcohol: market assessment and the need to have a functional prevention and treatment strategy. Link


A progress dependent dynamic valuation model for healthcare solution development. Link


Innovation case study (Transvac) – designing an international early stage innovation ecosystem: link

Socioeconomic needs – putting health value before financial gain: link


Digital Health Solutions 

Picture 1.png